$PPSI
PIONEER POWER SOLUTIONS, INC.

2024 Q3 Form 10-Q Financial Statement

#000149315224045402 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $10.91M $12.44M
YoY Change -12.31% 99.06%
Cost Of Revenue $8.845M $8.732M
YoY Change 1.29% 62.0%
Gross Profit $2.066M $3.711M
YoY Change -44.33% 331.01%
Gross Profit Margin 18.94% 29.82%
Selling, General & Admin $2.907M $2.758M
YoY Change 5.4% 19.65%
% of Gross Profit 140.71% 74.32%
Research & Development $256.0K
YoY Change
% of Gross Profit 12.39%
Depreciation & Amortization $185.0K $143.0K
YoY Change 29.37% 257.5%
% of Gross Profit 8.95% 3.85%
Operating Expenses $3.163M $2.758M
YoY Change 14.68% 19.65%
Operating Profit -$1.097M $953.0K
YoY Change -215.11% -166.0%
Interest Expense -$23.00K $60.00K
YoY Change -138.33% -48.28%
% of Operating Profit 6.3%
Other Income/Expense, Net -$1.000K $11.00K
YoY Change -109.09% -35.29%
Pretax Income -$1.121M $1.024M
YoY Change -209.47% -178.11%
Income Tax
% Of Pretax Income
Net Earnings -$1.121M $1.024M
YoY Change -209.47% -178.11%
Net Earnings / Revenue -10.27% 8.23%
Basic Earnings Per Share -$0.10 $0.10
Diluted Earnings Per Share -$0.10 $0.10
COMMON SHARES
Basic Shares Outstanding 10.92M shares 10.01M shares
Diluted Shares Outstanding 10.92M shares 10.25M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.080M $7.581M
YoY Change -59.37% 5.15%
Cash & Equivalents $3.080M $7.581M
Short-Term Investments
Other Short-Term Assets $2.476M $5.518M
YoY Change -55.13% 556.9%
Inventory $16.10M $8.280M
Prepaid Expenses
Receivables $9.799M $8.936M
Other Receivables $0.00 $0.00
Total Short-Term Assets $31.45M $30.32M
YoY Change 3.76% 14.61%
LONG-TERM ASSETS
Property, Plant & Equipment $4.705M $3.775M
YoY Change 24.64% 375.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $75.00K $82.00K
YoY Change -8.54% -2.38%
Total Long-Term Assets $8.604M $5.446M
YoY Change 57.99% 81.9%
TOTAL ASSETS
Total Short-Term Assets $31.45M $30.32M
Total Long-Term Assets $8.604M $5.446M
Total Assets $40.06M $35.76M
YoY Change 12.02% 21.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.627M $4.961M
YoY Change 94.05% 44.51%
Accrued Expenses $1.444M $4.811M
YoY Change -69.99% 277.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $120.0K $157.0K
YoY Change -23.57% -55.27%
Total Short-Term Liabilities $22.35M $16.61M
YoY Change 34.54% 35.08%
LONG-TERM LIABILITIES
Long-Term Debt $173.0K $320.0K
YoY Change -45.94% -31.91%
Other Long-Term Liabilities $36.00K $53.00K
YoY Change -32.08% -95.94%
Total Long-Term Liabilities $36.00K $53.00K
YoY Change -32.08% -95.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.35M $16.61M
Total Long-Term Liabilities $36.00K $53.00K
Total Liabilities $25.38M $17.26M
YoY Change 47.02% 26.9%
SHAREHOLDERS EQUITY
Retained Earnings -$24.07M -$15.12M
YoY Change 59.15% -10.5%
Common Stock $11.00K $10.00K
YoY Change 10.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.68M $18.50M
YoY Change
Total Liabilities & Shareholders Equity $40.06M $35.76M
YoY Change 12.02% 21.45%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.121M $1.024M
YoY Change -209.47% -178.11%
Depreciation, Depletion And Amortization $185.0K $143.0K
YoY Change 29.37% 257.5%
Cash From Operating Activities -$2.739M -$598.0K
YoY Change 358.03% -74.17%
INVESTING ACTIVITIES
Capital Expenditures $663.0K $1.535M
YoY Change -56.81% -807.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$663.0K -$1.535M
YoY Change -56.81% 607.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.00K 88.00K
YoY Change -134.09% -304.65%
NET CHANGE
Cash From Operating Activities -2.739M -598.0K
Cash From Investing Activities -663.0K -1.535M
Cash From Financing Activities -30.00K 88.00K
Net Change In Cash -3.432M -2.045M
YoY Change 67.82% -20.58%
FREE CASH FLOW
Cash From Operating Activities -$2.739M -$598.0K
Capital Expenditures $663.0K $1.535M
Free Cash Flow -$3.402M -$2.133M
YoY Change 59.49% 1.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8245000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001449792
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35212
dei Entity Registrant Name
EntityRegistrantName
PIONEER POWER SOLUTIONS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1347616
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Kelby Street
dei Entity Address Address Line2
EntityAddressAddressLine2
12th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Lee
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07024
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
867-0700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PPSI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11012503 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10911000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25841000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33291000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7755000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21394000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22882000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
3698000 usd
us-gaap Gross Profit
GrossProfit
4447000 usd
us-gaap Gross Profit
GrossProfit
10409000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2758000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8004000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2758000 usd
us-gaap Operating Expenses
OperatingExpenses
8950000 usd
us-gaap Operating Expenses
OperatingExpenses
8004000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
940000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4503000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
60000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
25000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
192000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1011000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4439000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2601000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1011000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4439000 usd
us-gaap Net Income Loss
NetIncomeLoss
2601000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10010226 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10652911 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9896850 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10250099 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10652911 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10049009 shares
CY2023Q4 us-gaap Cash
Cash
3582000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9010000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7579000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7512000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
27683000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3899000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
760000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
403000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12609000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
582000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
139000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4932000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18262000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
215000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
278000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
18804000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33837000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19629000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14218000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33022000 usd
us-gaap Net Income Loss
NetIncomeLoss
2601000 usd
us-gaap Depreciation
Depreciation
370000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
269000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
514000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1246000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1642000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1095000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2990000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2407000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4733000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-520000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-228000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2345000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2345000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Other Noncash Income
OtherNoncashIncome
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
PPSI Acquisition Of Right Of Use Assets And Lease Liabilities
AcquisitionOfRightOfUseAssetsAndLeaseLiabilities
usd
PPSI Deferred Financing Costs Included In Accounts Payable And Accrued Liabilities
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedLiabilities
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
PPSI Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedFairValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
PPSI Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedFairValue
usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2024Q3 PPSI Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedFairValue
usd
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11453000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8845000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2066000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2907000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
256000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
705000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3163000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1097000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2405000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-23000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1121000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1121000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10917038 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10917038 shares
CY2024Q3 us-gaap Cash
Cash
3080000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
97000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9799000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
16099000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2476000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
31454000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4705000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3546000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
278000 usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
195000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
75000 usd
CY2024Q3 us-gaap Assets
Assets
40058000 usd
CY2023Q4 us-gaap Assets
Assets
33022000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11071000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
751000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
120000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10409000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22351000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2818000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
173000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
25378000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10917038 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10917038 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9930022 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9930022 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
11000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38737000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24068000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14680000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40058000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4439000 usd
us-gaap Depreciation
Depreciation
471000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
93000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
551000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-46000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
80000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
334000 usd
us-gaap Other Noncash Income
OtherNoncashIncome
15000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
966000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8520000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5048000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-5000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1550000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5477000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-566000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4118000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1277000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1277000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4986000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
177000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
73000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
93000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
296000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4893000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-502000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2715000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3582 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10296 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3080 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7581 usd
us-gaap Interest Paid Net
InterestPaidNet
26000 usd
PPSI Acquisition Of Right Of Use Assets And Lease Liabilities
AcquisitionOfRightOfUseAssetsAndLeaseLiabilities
3337000 usd
PPSI Deferred Financing Costs Included In Accounts Payable And Accrued Liabilities
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedLiabilities
122000 usd
PPSI Surrender And Retirement Of Common Stock
SurrenderAndRetirementOfCommonStock
224000 usd
PPSI Surrender And Retirement Of Common Stock
SurrenderAndRetirementOfCommonStock
720000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17690000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1011000 usd
CY2023Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
285000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
720000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18492000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
15788000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1121000 usd
CY2024Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
13000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14680000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15152000 usd
us-gaap Net Income Loss
NetIncomeLoss
2601000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1246000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
720000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-14000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18492000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14218000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14218000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4439000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4439000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
334000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4791000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
224000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14680000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
14680000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2024Q3 PPSI Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1 pure
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3080000 usd
CY2024Q3 PPSI Working Capital Deficit
WorkingCapitalDeficit
9103000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
52000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
97000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
220000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2569000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2688000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8535000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10911000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11453000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25841000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33291000 usd
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
559000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1305000 usd
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
246000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
719000 usd
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
559000 usd
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
246000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1305000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
719000 usd
CY2024Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
559000 usd
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
246000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1305000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
719000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
10232000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5316000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
5867000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2263000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
16099000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7579000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7747000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6470000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3042000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2571000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4705000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3899000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
185000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
143000 usd
us-gaap Depreciation
Depreciation
471000 usd
us-gaap Depreciation
Depreciation
370000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9627000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5396000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1444000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7213000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11071000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12609000 usd
CY2024Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
364000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
442000 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
319000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
294000 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5000000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
224000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
67000 usd
CY2024Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
0 usd
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
795000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
706167 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5146 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
57000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.21
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
654313 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.07
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M14D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
507000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
636335 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M8D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
506000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
125000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.35
CY2023Q4 PPSI Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Unvested Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsUnvestedFairValue
543000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
125000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
543000 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
13000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
334000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
285000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1246000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
96000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1121000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1011000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4439000 usd
us-gaap Net Income Loss
NetIncomeLoss
2601000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10917038 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10010226 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10652911 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9896850 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
239873 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
152159 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10917038 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10250099 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10652911 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10049009 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2024Q3 us-gaap Revenues
Revenues
10911000 usd
CY2023Q3 us-gaap Revenues
Revenues
11453000 usd
us-gaap Revenues
Revenues
25841000 usd
us-gaap Revenues
Revenues
33291000 usd
CY2024Q3 us-gaap Revenues
Revenues
10911000 usd
CY2023Q3 us-gaap Revenues
Revenues
11453000 usd
us-gaap Revenues
Revenues
25841000 usd
us-gaap Revenues
Revenues
33291000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
215000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
207000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
564000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
639000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
215000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
207000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
564000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
639000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1097000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
940000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4503000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2405000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1097000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
940000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4503000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2405000 usd
CY2024Q3 PPSI Lease Asset And Liability After Adjusting Weighted Average Discount Rate
LeaseAssetAndLiabilityAfterAdjustingWeightedAverageDiscountRate
3337000 usd
CY2024Q3 PPSI Common Stock Adverse Party Percentage
CommonStockAdversePartyPercentage
0.05 pure

Files In Submission

Name View Source Status
0001493152-24-045402-index-headers.html Edgar Link pending
0001493152-24-045402-index.html Edgar Link pending
0001493152-24-045402.txt Edgar Link pending
0001493152-24-045402-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
ppsi-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ppsi-20240930_cal.xml Edgar Link unprocessable
ppsi-20240930_def.xml Edgar Link unprocessable
ppsi-20240930_lab.xml Edgar Link unprocessable
ppsi-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable